Atopic dermatitis burden scale: Creation of a specific burden questionnaire for families

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 11, 2013, Pages 1426-1432

  Meni C ^a   Bodemer, C ^a,b   Toulon, A ^a   Merhand, S ^c   Perez Cullell, N ^d   Branchoux, S ^e   Taieb, C ^e  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Association Francaise de l Eczema   (France)

^d Eau Thermale Avène   (France)

^e Centre d'Immunologie Pierre Fabre   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATOPIC DERMATITIS; ATOPIC DERMATITIS BURDEN SCALE; CHILD; CONCURRENT VALIDITY; CONSENSUS; CONSTRUCT VALIDITY; DISCRIMINANT VALIDITY; FACTORIAL ANALYSIS; FAMILY ASSESSMENT; FEMALE; HUMAN; INFANT; INTERNAL CONSISTENCY; LITERATURE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PATIENT ORIENTED SCORING INDEX OF ATOPIC DERMATITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; SCORING SYSTEM; SHORT FORM 12;

CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FAMILY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PSYCHOMETRICS; QUESTIONNAIRES;

EID: 84885947719     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12180     Document Type: Article

References (41)

1. Misery L, Ortonne JP, Cambazard F, et al,. PPAD: a tool for presumption of atopic dermatitis. J Dermatol 2012; 39: 151-155.
2. Bieber T,. Atopic dermatitis. N Engl J Med 2008; 358: 1483-1494.
3. Darsow U, Wollenberg A, Simon D, et al,. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2010; 24: 317-328.
4. Ellis C, Luger T, Abeck D, et al,. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol 2003; 148: 3-10.
5. Kalavala M, Dohil MA,. Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence. Am J Clin Dermatol 2011; 12: 15-24.
6. Schmitt J, Schmitt N, Meurer M,. Cyclosporin in the treatment of patients with atopic eczema-a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2007; 21: 606-619.
7. Taieb C, Sibaud V, Merial-Kieny C,. Impact of Avène hydrotherapy on the quality of life of atopic and psoriatic patients. J Eur Acad Dermatol Venereol 2011; 25: 24-29.
8. Kiebert G, Sorensen SV, Revicki D, et al,. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol 2002; 41: 151-158.
9. Finlay AY,. Quality of life in atopic dermatitis. J Am Acad Dermatol 2001; 45: S64-S66.
10. Rehal B, Armstrong AW,. Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010. PLoS ONE 2011; 6: e17520.
11. Weber MB, Fontes Neto Pde T, Prati C, et al,. Improvement of pruritus and quality of life of children with atopic dermatitis and their families after joining support groups. J Eur Acad Dermatol Venereol 2008; 22: 992-997.
12. Koblenzer CS,. Itching and the atopic skin. J Allergy Clin Immunol 1999; 104: S109-S113.
13. Dahl RE, Bernhisel-Broadbent J, Scanlon-Holdford S, et al,. Sleep disturbances in children with atopic dermatitis. Arch Pediatr Adolesc Med 1995; 149: 856-860.
14. Moore K, David TJ, Murray CS, et al,. Effect of childhood eczema and asthma on parental sleep and well-being: a prospective comparative study. Br J Dermatol 2006; 154: 514-518.
15. Whalley D, McKenna SP, Dewar AL, et al,. A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol 2004; 150: 274-283.
16. McKenna SP, Whalley D, Dewar AL, et al,. International development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD). Qual Life Res 2005; 14: 231-241.
17. Chamlin SL, Chren MM,. Quality-of-life outcomes and measurement in childhood atopic dermatitis. Immunol Allergy Clin North Am 2010; 30: 281-288.
18. World Health Organization. About the Global Burden of Disease (GBD) project [WWW document]. URL http://www.who.int/healthinfo/global-burden-disease/ about/en/ (last accessed 23 April 2010)
19. Guex JJ, Rahhali N, Taïeb C,. The patient's burden of chronic venous disorders: construction of a questionnaire. Phlebology 2010; 25: 280-285.
20. Meyer N, Paul C, Feneron D, et al,. Psoriasis: an epidemiological evaluation of disease burden in 590 patients. J Eur Acad Dermatol Venereol 2010; 24: 1075-1082.
21. Carroll CL, Balkrishnan R, Feldman SR, et al,. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol 2005; 22: 192-199.
22. Chamlin SL,. The psychosocial burden of childhood atopic dermatitis. Dermatol Ther 2006; 19: 104-107.
23. Fivenson D, Arnold RJ, Kaniecki DJ, et al,. The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization. J Manag Care Pharm 2002; 8: 333-342.
24. Lapidus CS,. Role of social factors in atopic dermatitis: the US perspective. J Am Acad Dermatol 2001; 45: (1 Suppl) S41-S43.
25. Seidenberg M, Haltiner A, Taylor MA, et al,. Development and validation of a multiple ability self-report questionnaire. J Clin Exp Neuropsychol 1994; 16: 93-103.
26. Serra E, Spaeth M, Carbonell J, et al,. Development of the Fibromyalgia Burden Assessment: Measuring the burden of fibromyalgia multifaceted. Clin Exp Rheumatol 2010; 28: S87-S93.
27. Marquis P., Développement et validation d'un questionnaire: état de l'art et niveau d'évidence requis. In:, Chassany O, Caulin C, eds. Qualité de vie liée à l'état de santé: critère d'évaluation. Coll. Recherche Clinique et Décision thérapeutique, Springer Verlag. Ed. 2002: 35-45.
28. Wild D, Grove A, Martin M, et al,. ISPOR Task Force for Translation and Cultural Adaptation. Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 2005; 8: 94-104.
29. Ware J Jr, Kosinski M, Keller SD,. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-233.
30. Stalder JF, Barbarot S, Wollenberg A, et al,. Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe. Allergy 2011; 66: 1114-1121.
31. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186: 23-31.
32. Cronbach LJ,. Coefficient alpha and the internal structure of tests. Psychometrica 1951; 16: 297-334.
33. Mancini AJ, Kaulback K, Chamlin SL,. The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol 2008; 25: 1-6.
34. Barbeau M, Bpharm HL,. Burden of Atopic dermatitis in Canada. Int J Dermatol 2006; 45: 31-36.
35. Ellis CN, Drake LA, Prendergast MM, et al,. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol 2002; 46: 361-370.
36. Hambleton RK, Jones RW,. Comparison of classical test theory and item response theory and their applications to test development. Educat Measure: Issues Pract 1993; 12: 38-47.
37. Rash G,. Probabilistic models for some intelligence and attainments tests. Danmarks Paedagogiske Institut, Copenhagen, 1960.
38. Eekhout I, de Boer RM, Twisk JW, de Vet HC, Heymans MW,. Missing data: a systematic review of how they are reported and handled. Epidemiology 2012; 23: 729-732.
39. De Bes J, Legierse CM, Prinsen CA, et al,. Patient education in chronic skin diseases: a systematic review. Acta Derm Venereol 2011; 91: 12-17.
40. Chavigny JM, Adiceom F, Bernier C, et al,. Assessment of an educational program in an 'Atopic School': pilot study in 40 patients. Ann Dermatol Venereol 2002; 129: 1003-1007.
41. Taieb C, Perez-Cullell N,. TEPAD: Therapeutic education: Tools for atopic dermatitis: A tool for evaluating therapeutic education in atopic dermatitis. J Am Acad Dermatol 2012; 66: 70.